BioCentury
ARTICLE | Clinical News

Anergen regulatory update

August 10, 1998 7:00 AM UTC

ANRG received U.S. Patent No. 5,763,585 covering manufacturing methods for its AnergiX compounds for autoimmune diseases. AnergiX technology combines disease-specific, auto-antigenic peptides with dis...